Powerful inner/outer controlled multi-target magnetic nanoparticle drug carrier prepared by liquid photo-immobilization

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Guan, Yan Qing ^a   Zheng, Zhe ^a   Huang, Zheng ^a   Li, Zhibin ^a   Niu, Shuiqin ^a   Liu, Jun Ming ^a,b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTIVIRUS AGENT; DOXORUBICIN; DRUG CARRIER; FOLIC ACID; GAMMA INTERFERON; MAGNETITE NANOPARTICLE; MESSENGER RNA; OLEIC ACID; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; GENETICS; HELA CELL LINE; HUMAN; LIGHT; METABOLISM; MOUSE; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HELA CELLS; HEMATINICS; HUMANS; INTERFERON-GAMMA; LIGHT; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; OLEIC ACID; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901247588     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04990     Document Type: Article

References (50)

1. Dilnawaz, F., Singh, A., Mohanty, C. & Sahoo, S. K. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31, 3694-3706 (2010).
2. Hua, M. Y. et al. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas. Biomaterials 32, 516-527 (2011).
3. Sun, C. et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 4, 2402-2410 (2010).
4. Veiseh, O., Gunn, J. W. & Zhang, M. Q. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62, 284-304 (2010).
5. Amstad, E. et al. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containingmembranes. Nano Lett. 11, 1664-1670 (2011).
6. Hoare, T. et al. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett. 11, 1395-400 (2011).
7. Kim, D. H. et al. Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nat. Mater. 9, 165-171 (2010).
8. Mikhaylov, G. et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat. Nanotechnol. 6, 594-602 (2011).
9. Lan, Q. et al. Synthesis of bilayer oleic acid-coated Fe3O4 nanoparticles and their application in pH-responsive Pickering emulsions. J. Colloid. Interf. Sci. 310, 260-269 (2007). (Pubitemid 46560549)
10. Namiki, Y. et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat. Nanotechnol. 4, 598-606 (2009).
11. Nunes, J., Herlihy, K. P., Mair, L., Superfine, R. & Simone, J. M. Multifunctional shape and size specific magneto-polymer composite particles. Nano Lett. 10,1113-1119 (2010).
12. Oh, J. K. & Park, J. M. Iron oxide-based superparamagnetic polymeric nanomaterials: Design, preparation, and biomedical application. Prog. Polym. Sci. 36,168-189 (2011).
13. Hao, R. et al. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater. 22, 2729-2742 (2010).
14. Shiokawa, T. et al. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin. Cancer Res. 11, 2018-2025 (2005). (Pubitemid 40471868)
15. Seow, W. Y., Xue, J. M. & Yang, Y. Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials 28, 1730-1740 (2007). (Pubitemid 46098966)
16. Brunel, F. M. et al. Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett. 10, 1093-1097 (2010).
17. Wang, J. F. et al. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules 12, 228-234 (2011).
18. Lee, H. et al.Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389-393 (2012).
19. Xiong, X. B., Ma, Z., Lai, R. & Lavasanifar, A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 31, 757-768 (2010).
20. Sun, H. L. et al. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 30, 6358-6366 (2009).
21. Zhang, W. et al. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties. Biomacromolecules 11, 1331-1338 (2010).
22. Jiang, S., Gnanasammandhan, M. K. & Zhang, Y. Optical imaging-guided cancer therapy with fluorescent nanoparticles. J. R. Soc. Interface 7, 3-18 (2010).
23. Horcajada, P. et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 9, 172-178 (2010).
24. Swift, L. P., Rephaeli, A.,Nudelman, A., Phillips, D. R.&Cutts, S. M. Doxorubicin- DNAadducts induce a non-topoisomerase II-mediated form of cell death. Cancer. Res. 66, 4863-4671 (2006).
25. Pommier, Y., Leo, E., Zhang, H. L.&Marchand, C.DNAtopoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 17, 421-433 (2010).
26. Ito, Y. Photo-immobilization for microarrays. Biotechnol. Prog. 22, 924-932 (2006).
27. Ito, Y., Liu, S. Q. & Imanishi, Y. Enhancement of cell growth on growth factorimmobilized polymer film. Biomaterials 12, 449-453 (1991).
28. Gümüşderelioǧlu,- M. & Türkoǧlu, H. Biomodification of non-woven polyester fabrics by insulin and RGD for use in serum-free cultivation of tissue cells. Biomaterials 23, 3927-3935 (2002). (Pubitemid 34756746)
29. Kang, I. K., Kim, G. J., Kwon, O. H. & Ito, Y. Co-culture of hepatocytes and fibroblasts by micropatterned immobilization of b-galactose derivatives. Biomaterials 25, 4225-4232 (2004). (Pubitemid 38388583)
30. Guo, L. et al. Chondrogenic differentiation of human mesenchymal stem cells on photoreactive polymer-modified surfaces. Biomaterials 29, 23-32 (2008). (Pubitemid 47599651)
31. Hoshiba, T., Kawazoe, N., Tateishi, T. & Chen, G. P. Development of extracellular matrices mimicking stepwise adipogenesis of mesenchymal stem cells. Adv. Mater. 22, 3042-3047 (2010).
32. Aggarwal, B. B., Eessalu, T. E. & Hass, P. E. Characterization of receptors for human tumor necrosis factor and their regulation by r-interferon. Nature 318, 665-667 (1985). (Pubitemid 16172416)
33. Yarden, A. & Kimchi, A. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science 234, 1419-1421 (1986). (Pubitemid 17210226)
34. Mookerjee, A. et al. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis. Clin. Cancer. Res. 12, 4339-4349 (2006).
35. Khan, T. et al. Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. J. Immunol. 176, 6302-6012 (2006).
36. Guan, Y.Q., He, L.M., Cai, S. M.&Zhou, T. H. Anti-cervix-cancer effect of the coimmobilized tumor necrosis factor-a and interferon-r. J. Mater. Sci. Technol. 22, 200-206 (2006).
37. Guan, Y. Q., Li, Z. B. & Liu, J. M. Death signal transduction induced by coimmobilized TNF-a plus IFN-c and the development of polymeric anti-cancer drugs. Biomaterials 31, 9074-9085 (2010).
38. Guan, Y. Q. et al. Pathway of programmed cell death in HeLa cells induced by polymeric anti-cancer drugs. Biomaterials 32, 3637-3646 (2011).
39. Guan, Y. Q. et al. Cell cycle arrest and apoptosis of OVCAR-3 and MCF-7 cells induced by co-immobilized TNF-a plus IFN-c on polystyrene and the role of p53 activation. Biomaterials 33, 1682-1687 (2012).
40. Wu, W. T. et al. Multi-functional core-shell hybrid nanogels for pH-dependent magnetic manipulation, fluorescent pH-sensing, and drug delivery. Biomaterials 32, 9876-9887 (2011).
41. Chen, Y. et al. Structure-property relationships in manganese oxide -mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials 33, 2388-2398 (2012).
42. Fuchigami, T., Kawamura, R., Kitamoto, Y., Nakagawa, M. & Namiki, Y. A magnetically guided anti-cancer drug delivery system using porous FePt capsules. Biomaterials 33, 1682-1687 (2012).
43. He, Q. J., Ma, M., Wei, C. Y. & Shi, J. L. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging. Biomaterials 33, 4392-4402 (2012).
44. Wang, H. et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32, 8281-8290 (2011).
45. Jiang, X. Y. et al. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials 32, 9457-9468 (2011).
46. Ernsting, M. J., Foltz, W. D., Undzys, E., Tagami, T. & Li, S. D. Tumor-targeted drug delivery using MR-contrasted docetaxel- Carboxymethylcellulose nanoparticles. Biomaterials 33, 3931-3941 (2012).
47. Chen, K. J. et al. The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles. Biomaterials 33, 1162-1169 (2012).
48. Huang, X. X., Tran, T., Zhang, L. N., Hatcher, R. & Zhang, P. M. DNA damageinduced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. PNAS 102, 1065-1070 (2005). (Pubitemid 40170726)
49. Hamer, P. C. D. W.,Mir, S., Noske, D.,Noorden, C. J. F. V.&Würdinger, T. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin. Cancer Res. 17, 4200-4207 (2011).
50. Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell Bio. 12, 1-8 (2011).